01273nas a2200217   4500000000100000008004100001653002600042653001300068653003900081653001700120653002300137100001400160700001500174700001500189245007500204856007400279300000800353490000700361520067300368022001401041       2019                            d10aAccess to health care10aMigrants10aNeglected tropical diseases (NDTs)10aOrphan drugs10aParasitic Diseases1 aCalleri G1 aAngheben A1 aAlbonico M00aNeglected tropical diseases in Europe: rare diseases and orphan drugs?  uhttps://link.springer.com/content/pdf/10.1007%2Fs15010-018-1241-2.pdf  a3-50 v473 a<p>Neglected tropical diseases are becoming more and more frequent in Europe due to the increasing immigration from endemic areas. Nonetheless specific treatments are scarcely available in many European countries, since they are neither officially licensed nor marketed. Only a few referral health centres can afford to access drugs for NTDs due to complex bureaucracy and high cost, importing or providing them via the WHO. Health professionals and institutions in this domain should solicit other stakeholders (such as NGOs, the civil society, scientific societies) to sensitize health authorities to improve access to treatment for such debilitating diseases.</p>
  a1439-0973